Bisfosfonatos podem minimizar a fome óssea após paratireoidectomia em pacientes com hiperparatireoidismo primário e osteíte fibrosa cística

França, Tatiana Clementino Pinto Toscano de; Griz, Luiz; Pinho, Jorge; Diniz, Erik Trovão; Andrade, Luena Dias de; Lucena, Cynthia Salgado; Beserra, Susyane Ribeiro; Asano, Nadja Maria Jorge; Duarte, Ângela Pinto; Bandeira, Francisco.
Rev. bras. reumatol ; 51(2): 131-137, mar.-abr. 2011. tab
Artigo em Português | LILACS | ID: lil-586718

Documentos relacionados

  1. Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica.
  2. Hungry bone syndrome.
  3. Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients.
  4. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
  5. Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET<sup>®</sup> in Japan: a new-user cohort study.
  6. Influence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats.
  7. Hypercalcaemia to hypocalcaemia: tetany as a side effect of intravenous bisphosphonate treatment.
  8. Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.
  9. Evaluation of preoperative procollagen type 1 N-terminal peptide and collagen type 1 C-telopeptide levels in the prediction of postoperative hypocalcemia in patients undergoing parathyroidectomy due to primary hyperparathyroidism.
  10. Prevalence of baseline hypocalcemia and symptomatic hypocalcemia during leukapheresis.